Pharmacodynamic studies indicated apoptosis in peripheral blood CLL cells within 3 to 6 hours after dasatinib administration, which interestingly was associated with downregulation of SYK mRNA. This evidence concerns the gene SYK and B-cell chronic lymphocytic leukemia.